Episode 29 - Adrian Rawcliffe, CEO of Adaptimmune episode artwork

EPISODE · Dec 18, 2024 · 44 MIN

Episode 29 - Adrian Rawcliffe, CEO of Adaptimmune

from The BioHub: The Top Voices in Biotech · host Max Brennan - Biotech HeadHunter

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. I’m pleased to introduce Adrian Rawcliffe, CEO of Adaptimmune Therapeutics. With over 20 years of experience in the pharmaceutical and biotech industries, Adrian has led pivotal roles at GSK and now spearheads the development of breakthrough T-cell therapies at Adaptimmune, tackling some of the toughest challenges in cancer and beyond. We’re excited to dive into Adrian’s journey, the advancements at Adaptimmune, and what the future holds for T-cell therapies. Welcome to the show, Adrian! Enjoy and stay tuned.

NOW PLAYING

Episode 29 - Adrian Rawcliffe, CEO of Adaptimmune

0:00 44:57

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The BioHub: The Top Voices in Biotech?

This episode is 44 minutes long.

When was this The BioHub: The Top Voices in Biotech episode published?

This episode was published on December 18, 2024.

What is this episode about?

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. I’m pleased to introduce Adrian Rawcliffe, CEO of Adaptimmune Therapeutics. With over 20 years of experience in the pharmaceutical and...

Can I download this The BioHub: The Top Voices in Biotech episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!